NF1 Antibody - #DF8681
製品: | NF1 Antibody |
カタログ: | DF8681 |
タンパク質の説明: | Rabbit polyclonal antibody to NF1 |
アプリケーション: | WB IF/ICC |
反応性: | Human, Mouse, Rat, Monkey |
予測: | Pig, Horse, Sheep, Rabbit, Dog, Xenopus |
分子量: | 319 kDa; 319kD(Calculated). |
ユニプロット: | P21359 |
RRID: | AB_2841885 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF8681, RRID:AB_2841885.
折りたたみ/展開
DKFZp686J1293; FLJ21220; Neurofibromatosis Noonan syndrome; Neurofibromatosis related protein NF 1; Neurofibromatosis related protein NF1; neurofibromatosis type I; Neurofibromatosis-related protein NF-1; Neurofibromin 1; Neurofibromin truncated; Neurofibromin1; NF 1; NF; NF1; NF1_HUMAN; NFNS; Type 1 Neurofibromatosis; von Recklinghausen disease neurofibromin; von Recklinghausen disease related protein VRNF; VRNF; WATS; Watson disease related protein WSS; Watson syndrome; WSS;
免疫原
- P21359 NF1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAAHRPVEWVQAVVSRFDEQLPIKTGQQNTHTKVSTEHNKECLINISKYKFSLVISGLTTILKNVNNMRIFGEAAEKNLYLSQLIILDTLEKCLAGQPKDTMRLDETMLVKQLLPEICHFLHTCREGNQHAAELRNSASGVLFSLSCNNFNAVFSRISTRLQELTVCSEDNVDVHDIELLQYINVDCAKLKRLLKETAFKFKALKKVAQLAVINSLEKAFWNWVENYPDEFTKLYQIPQTDMAECAEKLFDLVDGFAESTKRKAAVWPLQIILLILCPEIIQDISKDVVDENNMNKKLFLDSLRKALAGHGGSRQLTESAAIACVKLCKASTYINWEDNSVIFLLVQSMVVDLKNLLFNPSKPFSRGSQPADVDLMIDCLVSCFRISPHNNQHFKICLAQNSPSTFHYVLVNSLHRIITNSALDWWPKIDAVYCHSVELRNMFGETLHKAVQGCGAHPAIRMAPSLTFKEKVTSLKFKEKPTDLETRSYKYLLLSMVKLIHADPKLLLCNPRKQGPETQGSTAELITGLVQLVPQSHMPEIAQEAMEALLVLHQLDSIDLWNPDAPVETFWEISSQMLFYICKKLTSHQMLSSTEILKWLREILICRNKFLLKNKQADRSSCHFLLFYGVGCDIPSSGNTSQMSMDHEELLRTPGASLRKGKGNSSMDSAAGCSGTPPICRQAQTKLEVALYMFLWNPDTEAVLVAMSCFRHLCEEADIRCGVDEVSVHNLLPNYNTFMEFASVSNMMSTGRAALQKRVMALLRRIEHPTAGNTEAWEDTHAKWEQATKLILNYPKAKMEDGQAAESLHKTIVKRRMSHVSGGGSIDLSDTDSLQEWINMTGFLCALGGVCLQQRSNSGLATYSPPMGPVSERKGSMISVMSSEGNADTPVSKFMDRLLSLMVCNHEKVGLQIRTNVKDLVGLELSPALYPMLFNKLKNTISKFFDSQGQVLLTDTNTQFVEQTIAIMKNLLDNHTEGSSEHLGQASIETMMLNLVRYVRVLGNMVHAIQIKTKLCQLVEVMMARRDDLSFCQEMKFRNKMVEYLTDWVMGTSNQAADDDVKCLTRDLDQASMEAVVSLLAGLPLQPEEGDGVELMEAKSQLFLKYFTLFMNLLNDCSEVEDESAQTGGRKRGMSRRLASLRHCTVLAMSNLLNANVDSGLMHSIGLGYHKDLQTRATFMEVLTKILQQGTEFDTLAETVLADRFERLVELVTMMGDQGELPIAMALANVVPCSQWDELARVLVTLFDSRHLLYQLLWNMFSKEVELADSMQTLFRGNSLASKIMTFCFKVYGATYLQKLLDPLLRIVITSSDWQHVSFEVDPTRLEPSESLEENQRNLLQMTEKFFHAIISSSSEFPPQLRSVCHCLYQATCHSLLNKATVKEKKENKKSVVSQRFPQNSIGAVGSAMFLRFINPAIVSPYEAGILDKKPPPRIERGLKLMSKILQSIANHVLFTKEEHMRPFNDFVKSNFDAARRFFLDIASDCPTSDAVNHSLSFISDGNVLALHRLLWNNQEKIGQYLSSNRDHKAVGRRPFDKMATLLAYLGPPEHKPVADTHWSSLNLTSSKFEEFMTRHQVHEKEEFKALKTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPDSIPQHTKIRPKDVPGTLLNIALLNLGSSDPSLRSAAYNLLCALTCTFNLKIEGQLLETSGLCIPANNTLFIVSISKTLAANEPHLTLEFLEECISGFSKSSIELKHLCLEYMTPWLSNLVRFCKHNDDAKRQRVTAILDKLITMTINEKQMYPSIQAKIWGSLGQITDLLDVVLDSFIKTSATGGLGSIKAEVMADTAVALASGNVKLVSSKVIGRMCKIIDKTCLSPTPTLEQHLMWDDIAILARYMLMLSFNNSLDVAAHLPYLFHVVTFLVATGPLSLRASTHGLVINIIHSLCTCSQLHFSEETKQVLRLSLTEFSLPKFYLLFGISKVKSAAVIAFRSSYRDRSFSPGSYERETFALTSLETVTEALLEIMEACMRDIPTCKWLDQWTELAQRFAFQYNPSLQPRALVVFGCISKRVSHGQIKQIIRILSKALESCLKGPDTYNSQVLIEATVIALTKLQPLLNKDSPLHKALFWVAVAVLQLDEVNLYSAGTALLEQNLHTLDSLRIFNDKSPEEVFMAIRNPLEWHCKQMDHFVGLNFNSNFNFALVGHLLKGYRHPSPAIVARTVRILHTLLTLVNKHRNCDKFEVNTQSVAYLAALLTVSEEVRSRCSLKHRKSLLLTDISMENVPMDTYPIHHGDPSYRTLKETQPWSSPKGSEGYLAATYPTVGQTSPRARKSMSLDMGQPSQANTKKLLGTRKSFDHLISDTKAPKRQEMESGITTPPKMRRVAETDYEMETQRISSSQQHPHLRKVSVSESNVLLDEEVLTDPKIQALLLTVLATLVKYTTDEFDQRILYEYLAEASVVFPKVFPVVHNLLDSKINTLLSLCQDPNLLNPIHGIVQSVVYHEESPPQYQTSYLQSFGFNGLWRFAGPFSKQTQIPDYAELIVKFLDALIDTYLPGIDEETSEESLLTPTSPYPPALQSQLSITANLNLSNSMTSLATSQHSPGIDKENVELSPTTGHCNSGRTRHGSASQVQKQRSAGSFKRNSIKKIV
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P21359 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Ubiquitination | Uniprot | ||
K24 | Ubiquitination | Uniprot | |
K40 | Ubiquitination | Uniprot | |
K261 | Ubiquitination | Uniprot | |
K297 | Ubiquitination | Uniprot | |
K362 | Ubiquitination | Uniprot | |
K449 | Ubiquitination | Uniprot | |
S465 | Phosphorylation | Uniprot | |
T467 | Phosphorylation | Uniprot | |
K469 | Methylation | Uniprot | |
K471 | Methylation | Uniprot | |
K476 | Methylation | Uniprot | |
K476 | Ubiquitination | Uniprot | |
K478 | Ubiquitination | Uniprot | |
Y491 | Phosphorylation | Uniprot | |
K505 | Ubiquitination | Uniprot | |
S657 | Phosphorylation | Uniprot | |
S674 | Phosphorylation | Uniprot | |
T676 | Phosphorylation | Uniprot | |
K783 | Ubiquitination | Uniprot | |
K796 | Ubiquitination | Uniprot | |
K798 | Ubiquitination | Uniprot | |
S807 | Phosphorylation | Uniprot | |
K810 | Ubiquitination | Uniprot | |
T862 | Phosphorylation | Uniprot | |
Y863 | Phosphorylation | Uniprot | |
S864 | Phosphorylation | Uniprot | |
K874 | Ubiquitination | Uniprot | |
S876 | Phosphorylation | Uniprot | |
S879 | Phosphorylation | Uniprot | |
S882 | Phosphorylation | Uniprot | |
S883 | Phosphorylation | Uniprot | |
T915 | Phosphorylation | Uniprot | |
S926 | Phosphorylation | Uniprot | |
Y930 | Phosphorylation | Uniprot | |
K1036 | Ubiquitination | Uniprot | |
R1204 | Methylation | Uniprot | |
K1283 | Acetylation | Uniprot | |
T1456 | Phosphorylation | Uniprot | |
K1517 | Ubiquitination | Uniprot | |
Y1521 | Phosphorylation | Uniprot | |
S1567 | Phosphorylation | Uniprot | |
K1581 | Acetylation | Uniprot | |
K1701 | Ubiquitination | Uniprot | |
K1745 | Ubiquitination | Uniprot | |
T1751 | Phosphorylation | Uniprot | |
K2049 | Ubiquitination | Uniprot | |
S2188 | Phosphorylation | Uniprot | |
Y2192 | Phosphorylation | Uniprot | |
T2444 | Phosphorylation | Uniprot | |
S2446 | Phosphorylation | Uniprot | |
S2451 | Phosphorylation | Uniprot | |
S2460 | Phosphorylation | Uniprot | |
Y2476 | Phosphorylation | Uniprot | |
K2489 | Methylation | Uniprot | |
K2489 | Ubiquitination | Uniprot | |
T2491 | Phosphorylation | Uniprot | |
S2495 | Phosphorylation | Uniprot | |
S2496 | Phosphorylation | Uniprot | |
S2500 | Phosphorylation | Uniprot | |
Y2503 | Phosphorylation | Uniprot | |
T2507 | Phosphorylation | Uniprot | |
Y2508 | Phosphorylation | Uniprot | |
T2514 | Phosphorylation | Uniprot | |
S2515 | Phosphorylation | Uniprot | |
S2521 | Phosphorylation | Uniprot | |
S2523 | Phosphorylation | Uniprot | |
S2543 | Phosphorylation | Uniprot | |
S2561 | Phosphorylation | Uniprot | |
T2564 | Phosphorylation | Uniprot | |
T2565 | Phosphorylation | Uniprot | |
T2575 | Phosphorylation | Uniprot | |
Y2577 | Phosphorylation | Uniprot | |
T2581 | Phosphorylation | Uniprot | |
S2587 | Phosphorylation | Uniprot | |
K2595 | Ubiquitination | Uniprot | |
S2597 | Phosphorylation | Uniprot | |
S2599 | Phosphorylation | Uniprot | |
S2802 | Phosphorylation | Uniprot | |
S2810 | Phosphorylation | Uniprot | |
S2817 | Phosphorylation | Uniprot | |
S2819 | Phosphorylation | Uniprot | |
S2829 | Phosphorylation | Uniprot | |
S2834 | Phosphorylation | Uniprot |
研究背景
Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity.
Nucleus. Nucleus>Nucleolus.
Detected in brain, peripheral nerve, lung, colon and muscle.
Interacts with HTR6.
Binds phospholipids via its C-terminal CRAL-TRIO domain. Binds primarily glycerophospholipids with monounsaturated C18:1 and/or C16:1 fatty acid moieties and a phosphatidylethanolamine or phosphatidylcholine headgroup. Has lesser affinity for lipids containing phosphatidylserine and phosphatidylinositol.
研究領域
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > EGFR tyrosine kinase inhibitor resistance.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.